Expression under the control of Scer\GAL4¹⁴⁰⁷ may result in mild defects in the shape of ganglion mother cells in the larval brain (depending on the insertion line used).

Expression under the control of Scer\GAL4¹⁴⁰⁷ may result in loss of neuroblasts in the larval brain without any change in size of the remaining neuroblasts (depending on the insertion line used).

Expression under the control of Scer\GAL4¹⁴⁰⁷ may result in shorter neuroblast lineages (less daughter cells per neuroblast) in the larval brain compared to controls (depending on the insertion line used).

Adults expressing eIF5^GD14146 under the control of the cardioblast-specific Scer\GAL4^tin.CΔ4 driver show significantly reduced survival on day 6 after a shift to 29[o]C compared to control flies.

Adults expressing eIF5^GD14146 under the control of Scer\GAL4^elav.PLu (in the presence of Dcr-2^Scer\UAS.cDa to increase the efficiency of RNAi) do not show a significant defect in avoidance of noxious temperature (46[o]C) compared to control flies.

Depending on the insertion line used, expression under the control of Scer\GAL4^Mef2.PR can result in late larval lethality or late pupal lethality.

Expression under the control of Scer\GAL4^Mef2.PR results in grossly normal larval body wall muscles.

Expression under the control of Scer\GAL4^Mef2.PR results in wild-type sarcomeres in the larval body wall muscles.

Expression under the control of Scer\GAL4^pnr-MD237 results in lethality (either before or at the pupal stage), depending on the insertion line used.